BLBao-Sen Li

Bao-Sen Li

*This is an algorithmically generated author record based on publicly available information.

Bao-Sen Li has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis

    by Lifeng Wang, Ying Sun, Zheng Zhang, Yiqiong Jia, Zhengsheng Zou, Jinbiao Ding, Yuanyuan Li, Xiangsheng Xu, Lei Jin, Tao Yang, et al.

    There is increasing interest in the role of T follicular helper (Tfh) cells in autoimmunity from the perspective of both their role in breach of tolerance and their effects on the natural history of disease progression. Indeed, the critical role of Tfh cells in autoimmunity is further highlighted based on their location in the germinal center (GC), a pathogenic hot spot for development of autoreactivity. To address the role of Tfh cells in primary biliary cirrhosis (PBC), we comprehensively evaluated the immunobiology of CXCR5+CD4+ Tfh cells in 69 patients with PBC, including a nested subgroup of 16 autoimmune hepatitis (AIH) and 20 healthy controls (HC), followed for 1 year. We report herein several key observations. First, there was an increased frequency of circulating Tfh cells in patients with PBC compared to AIH (P < 0.05) and HC (P < 0.01). Second, the function of circulating Tfh cells from PBC patients, including interleukin (IL)‐21 production (P < 0.05), the ability to promote B‐cell maturation, and autoantibody production, were greater than HC. Third, the frequency of these cells was significantly decreased in ursodeoxycholic acid (UDCA) responders compared to UDCA‐treated nonresponders, in both cross‐sectional (P = 0.023) and longitudinal studies (P = 0.036), respectively. Indeed, similar increases of Tfh cells were noted in liver and spleen. Conclusion: These results significantly extend our understanding of lymphoid subpopulations in PBC and their relative role in disease expression. Our data also provide a novel biomarker for evaluation of the effectiveness of new therapeutic approaches. (Hepatology 2015;61:627‐638)


  • Combination Therapy for Patients Decompensated Liver Cirrhosis with HCV Infection.

    by Yan Sun, Benkang Chang, Gaojun Teng, Weiwei Zhang, Jingjing Zhao, Zhiqiang Zou, Bin Li

  • Open Access

    Hyper-Activated Pro-Inflammatory CD16+ Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B

    by Ji-Yuan Zhang, Zheng-Sheng Zou, Ang Huang, Zheng Zhang, Jun-Liang Fu, Xiang-Sheng Xu, Li-Ming Chen, Bao-Sen Li, Fu-Sheng Wang

    Extensive mononuclear cell infiltration is strongly correlated with liver damage in patients with chronic hepatitis B virus (CHB) infection. Macrophages and infiltrating monocytes also participate in the development of liver damage and fibrosis in animal models. However, little is known regarding the immunopathogenic role of peripheral blood monocytes and intrahepatic macrophages. The frequencies, phenotypes, and functions of peripheral blood and intrahepatic monocyte/macrophage subsets were analyzed in 110 HBeAg positive CHB patients, including 32 immune tolerant (IT) carriers and 78 immune activated (IA) patients. Liver biopsies from 20 IA patients undergoing diagnosis were collected for immunohistochemical analysis. IA patients displayed significant increases in peripheral blood monocytes and intrahepatic macrophages as well as CD16+ subsets, which were closely associated with serum alanine aminotransferase (ALT) levels and the liver histological activity index (HAI) scores. In addition, the increased CD16+ monocytes/macrophages expressed higher levels of the activation marker HLA-DR compared with CD16− monocytes/macrophages. Furthermore, peripheral blood CD16+ monocytes preferentially released inflammatory cytokines and hold higher potency in inducing the expansion of Th17 cells. Of note, hepatic neutrophils also positively correlated with HAI scores. These distinct properties of monocyte/macrophage subpopulations participate in fostering the inflammatory microenvironment and liver damage in CHB patients and further represent a collaborative scenario among different cell types contributing to the pathogenesis of HBV-induced liver disease.


    • 1 October 2008
      • Vol. 22  (5) , 362-3

    [Primary application of identification-aided system for diagnosis and differential diagnosis of emerging infectious diseases].

    by Ye-Dong Wang, Shao-Li You, Bao-Sen Li, Jun Zhao, Jing He, Yi-Hui Rong, Li-Ming Chen, Bin-Xia Chang, Jia-He Tian, Xian-Zhi Zhou, et al.

    To verify the rate of diagnostic fitting between the clinic and the indentification-aided for diagnosis and differential diagnosis system, for emerging infections diseases (EID) established. 314 cases of 49 kinds of contagious diseases diagnosed and another 186 patients with fever who not diagnosed were tested by the system. Preliminary verification was made in 314 cases diagnosed which classified to 49 kinds of contagious diseases of infectious diseases and the results showed that the coincidence rate of clinical diagnosis and first diagnosis of this system was 61.9%; the suggestive rate of first three diagnoses was 78.1%, and that of first five diagnoses was 86.6%. The diagnosis of another 186 patients with fever were diagnosed by the system and the results showed that the coincidence rate of clinical diagnosis and first diagnosis was 59.7%; the suggestive rate of first three diagnoses was 77.9%, and that of first five diagnoses was 85.4%. The system can accurately suggest impossible diagnosis and differential diagnosis, and be useful for our medical work.

    • 11 September 2007
      • Vol. 87  (34) , 2416-9

    [Immunologically-competent cells in liver infiltrating lymphocytes in patients with chronic severe hepatitis B].

    by Zheng-Sheng Zou, Dong-Ping Xu, Bao-Sen Li, Lei Huang, Jun-Liang Fu, Zheng Zhang, Lei Jin, Qing-Feng Liu, Hui Zhang, Shao-Jie Xin, et al.

    To investigate the frequencies of immunologically competent cells (ICCs) in the liver-infiltrating lymphocytes (LILs) and peripheral blood and their possible role in pathogenesis in patients with chronic severe hepatitis B (CSHB). LILs were isolated from the liver tissue samples from 11 CSHB patients and 5 normal controls (NCs) by the method of combined grinding with semi-frosted microscopic slides and sedimentation of hepatic cells. The frequency of isolated ICCs, including CD3(+), CD4(+), and CD8(+) T-cells, NK cells, NKT cells, and B cells was examined and compared with that of the circulating ICCs in the CSHB patients. Comparison was conducted between the CSHB patients and the controls. (1) In the CSHB patients, the frequencies of CD4(+) T cells and B cells in LILs were 17% +/- 6% and 3.0% +/- 1.0% respectively, both significantly lower than those in the circulating blood (32% +/- 8% and 21.4% +/- 12.2% respectively, both P < 0.01); however, the frequencies of CD8(+) T cells, NK cells, and NKT cells in LILs were 38% +/- 13%, 34% +/- 18%, and 10% +/- 4% respectively, all significantly lower than those in the circulating blood (26% +/- 6%, 15% +/- 9%, and 6% +/- 4%, all P < 0.05). (2) The frequencies of infiltrating CD3(+) T cells and CD4(+) T cells of the CSHB patients were both significantly higher than those of the NCs (P = 0.042 and P = 0.001); and the frequency of infiltrating CD8(+) T cells of the CSHB patients was higher than that of the NCs, and the and the frequencies of infiltrating NK cells and NKT cells in LILs were lower than those of the NCs, however, not significantly. (3) Compared with the liver tissues from the NCs, the liver tissues from the CSHB patients exhibited a significantly higher ratio of liver-infiltrating CD4(+) T cells to peripheral blood CD4(+) T-cell subsets (P = 0.001), and significantly lower ratios of liver-infiltrating NKT cells and B cells to the peripheral blood NKT-cells and B cells (P = 0.029 and P = 0.001 respectively). The abundant infiltrating immune active cells, especially the CD4(+) T cells, CD8(+) T cells, and NK cells, may be the causal factors that drive the progressive development of CSHB.


    • 1 October 2006
      • Vol. 14  (10) , 788-9

    [Targeting the MDM2 gene using antisense oligonucleotide to induce cell apoptosis in human hepatoblastoma cell line HepG2].

    by Guang-Ju Teng, Guang-Shou Teng, Bao-Sen Li, Zheng-Sheng Zou, Wei Zhang, Jun Zhao, Bing-Xia Chang, Yan Tang

    • 1 September 2003
      • Vol. 17  (3) , 274-6

    [Detection of coagulation factor V in patients with severe hepatitis and its clinical significance].

    by Zheng-Sheng Zou, Zhi-Guo Liu, Ju-Mei Chen, Han-Qian Xing, Yuan-Li Mao, Bao-Sen Li, Shao-Jie Xin, Shao-Li You, Yi-Hui Rong

    To investigate the prognostic significance and role of coagulation factor V (CFV) levels in clinical diagnostic criteria for severe hepatitis. The CFV level and prothrombin activity (PTA) were tested by turbidimetry for 129 times in 58 patients with severe hepatitis. Comparative studies and clinical significance of CFV and PTA were analyzed by SPSS and SDAS softwares. 1. The levels of CFV and PTA were 15.3%+/-9.7% and 23.5%+/-10.0%, respectively, at the onset of severe hepatitis. 2. The mortality of severe hepatitis gradually increased with the gradual decrease of CFV or PTA during the most severe stage of the illness (P=0.000). 3. The levels of CFV and PTA decreased continually and rapidly in patients who died but gradually increased in survivors. The decrease or increase of PTA preceded that of CFV on the exacerbation or convalescent stage. 4. Hepatic encephalopathy occurred in 14 cases (24.14%). In 10 cases, it occurred in the terminal stage of the illness, far later than the time of the decrease of CFV. 5. The level of CFV was closely related to PTA (the correlation coefficient was 0.812), the level of CFV was almost consistent with that of PTA. 1. The level of CFV is an important prognostic indicator in severe hepatitis and is more specific than PTA. 2. Simultaneous determination of CFV and PTA may be helpful in earlier and more accurate diagnosis of severe hepatitis. 3. Possible use of CFV as one of the criteria for liver transplantation in patients with severe hepatitis should be studied.


    • 1 December 2002
      • Vol. 16  (4) , 322-5

    [Features of onset of chronic severe hepatitis in 520 cases].

    by Zhengsheng Zou, Jumei Chen, Shaojie Xin, Hanqian Xing, Baosen Li, Jianyu Li, Honghui Shen, Yanping Liu

    To discuss features of onset of chronic severe viral hepatitis (CSH). The patterns of onset of 520 cases of CSH were analyzed by SPASS and STATA software. 1. Within less than 10 days, less than 2 weeks, 2 to 4 weeks, 4 weeks to 6 months, 10.4%, 18.1%, 17.1% and 64.8% of 520 cases deteriorated into severe hepatitis respectively. 2. There were no definite predisposing factors in more than 40% cases. There were 1 to 3 or more predisposing factors in more than 30% cases. The incidence of concurrent infection was the highest (P<0.01). 3. The pathogenic basis in more than 50% cases was cirrhosis. 4. Hepatic encephalopathy did not occur in more than 50% of the cases. Ascites occurred in more than 75% of cases. Hepatic encephalopathy first occurred in less than 5% cases and ascites in more than 10% of cases. 5. The latest time for occurrence of hepatic encephalopathy was later than the time of deteriorating into severe hepatitis. 1. Gradual deterioration into CSH was found in all the 520 cases. 2. The predisposing factors, pathogenic bases, incidence and occurring time of hepatic encephalopathy, firstly occurring complication and so on in CSH are not the same as those in acute and subacute severe hepatitis. Therefore, CSH should be independently named and the study of CSH should be strengthened.


    • 1 September 2002
      • Vol. 16  (3) , 246-8

    [Single factor study of prognosis from 520 cases with chronic severe hepatitis].

    by Zhengsheng Zou, Jumei Chen, Shaojie Xin, Hanqian Xing, Baosen Li, Jianyu Li, Honghui Shen, Yanping Liu

    To further understand chronic severe hepatitis (CSH) and to improve the level of diagnosis and treatment and to explore the methods to reduce the fatality rate of CSH through analysing the factors related to prognosis of CSH. The factors related to prognosis from 520 cases with CSH were analyzed by SPASS and STATA software. 1. The fatality rate in cases with age > or = 40 years was higher than that in cases with age 0.05) in sex and pathogenic basis of CSH; 2. The fatality rate rose in cases with WBC > or = 10.0 x 10(9) per liter or platelet or = 40 years, WBC 10.0 x 10(9) per liter or platelet <100 x 10(9) per liter; the ratio of AST/ALT, TBil, Tc, cholinesterase, Alb and complication, to monitor dynamically laboratory indexes such as TBil, PTA, Tc, cholinesterase and so on and to prevent and cure various complications are important measures to reduce the fatality rate of CSH.


    • 1 June 2002
      • Vol. 16  (2) , 157-9

    [Treatment of severe viral hepatitis with artificial liver support system].

    by Baosen Li, Shaojie Xin, Hanqian Xing, Jun Zhao, Zhengsheng Zou, Bin Zhang, Deyong Chen, Yuanli Mao

    To investigate the method and therapeutic efficacy of artificial liver support system (ALSS) in treatment of severe viral hepatitis. A total of 83 patients including 66 with severe viral hepatitis were treated with ALSS using Baxter-550 artificial kidney and Biologic-DT system. The levels of mean bilirubin, ALT, AST, BUN, Cr and endotoxin was significantly decreased after the treatment. Of the 66 patients?with severe viral hepatitis, 31(47.0%) had improvement in symptoms and 35 (53.0%) died or left hospital. In the control group,50(27.6%) out of the 181 had improvement in symptoms and 131(72.4%) died or left hospital. ALSS could exert certain therapeutic effects on severe viral hepatitis.